SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
SOLBERG LARRY D

(Last) (First) (Middle)
ONE CVS DRIVE

(Street)
WOONSOCKET RI 02895-

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CVS CORP [ CVS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2004
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/07/2004 M 30,898 A $16.7223 30,898 D
Common Stock 05/10/2004 S 30,898 D $41.007 0 D
Common Stock 17,395(1) I By Trust as Beneficiary
ESOP Preference Stock 303(2) I By ESOP
Common Stock (Restricted) 6,842 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $16.7223 05/07/2004 M 30,898 03/26/1997 05/14/2006 Common Stock 30,898 $0 0 D
Stock Option $23 02/17/2000 02/17/2007 Common Stock 26,100 26,100 D
Stock Option $25.125 01/09/2005 01/09/2013 Common Stock 30,000 30,000 D
Stock Option $29.925 01/02/2003 01/02/2012 Common Stock 42,421 42,421 D
Stock Option $35.335 01/08/2005 01/08/2011 Common Stock 35,000 35,000 D
Stock Option $36.6953 02/27/2001 02/27/2008 Common Stock 13,050 13,050 D
Stock Option $37.3125 03/12/2001 03/12/2008 Common Stock 30,000 30,000 D
Stock Option $38.5625 01/03/2002 01/03/2010 Common Stock 20,000 20,000 D
Stock Option $50 03/10/2001 03/10/2009 Common Stock 15,000 15,000 D
Stock Option $51.375 02/10/2002 02/10/2009 Common Stock 25,000 25,000 D
Stock Option $60.525 03/07/2003 03/07/2011 Common Stock 21,000 21,000 D
Explanation of Responses:
1. Includes dividend reinvestment shares acquired during the course of the year.
2. Reflects stock beneficially owned pursuant to issuer's ESOP Plan.
Larry Solberg 05/11/2004
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.